Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-11-19

Clinical Trial Update: Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears [Phase 4]

View source ↗

Summary

Phase 4 prospective registry IT-Disappears evaluating the use of ABSORB bioresorbable vascular scaffolds in Italian patients with diffuse or multivessel coronar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Absorb Bioresorbable Vascular Scaffold (bioresorbable vascular scaffold)

Snippet

Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN